Medcrypt’s Naomi Schwartz joins the Diabetes Technology Meeting to present on IEEE 2621 and its role in securing connected diabetes devices.
As the diabetes technology ecosystem becomes increasingly connected — from continuous glucose monitors to insulin delivery systems — the need for clear, scalable cybersecurity standards has never been greater.
At this year’s Diabetes Technology Meeting, held by the Diabetes Technology Society, Medcrypt’s Naomi Schwartz will present on the critical role of IEEE 2621, the first cybersecurity standard tailored specifically for diabetes devices.
Diabetes Technology Meeting 2025
October 28 – 30, 2025
San Francisco Airport Marriott Waterfront
Burlingame, California
“Cybersecurity by Design: Implementing IEEE 2621 in Connected Diabetes Devices”
Naomi will unpack the technical and regulatory implications of IEEE 2621, exploring:
Whether you're in R&D, product security, regulatory affairs, or digital health innovation, this session will help you navigate the evolving cybersecurity landscape for diabetes technology.
Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!
